SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 86845910. A total of 1 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $2,937,000 | +19.3% | 192,635 | +5.2% | 0.19% | +19.1% |
| Q4 2015 | $2,461,000 | +3.8% | 183,135 | +8.4% | 0.16% | +1.3% |
| Q3 2015 | $2,370,000 | -17.4% | 168,947 | 0.0% | 0.16% | -1.9% |
| Q2 2015 | $2,868,000 | +40.5% | 168,947 | 0.0% | 0.16% | +41.1% |
| Q1 2015 | $2,042,000 | +113.8% | 168,947 | +46.8% | 0.11% | +103.6% |
| Q4 2014 | $955,000 | – | 115,100 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 168,947 | $2,868,000 | 0.16% |